April 10, 2017 / 11:47 AM / in 6 months

BRIEF-Avivagen reports positive proof of concept in preventing C. Difficile infection

April 10 (Reuters) - Avivagen Inc -

* Avivagen reports positive proof of concept in preventing C. Difficile infection

* Study demonstrated highest dose of OxC-beta technology tested increased survivability in mice versus un-supplemented mouse control group Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below